CORE LABORATORIES INC (CLB) Stock Fundamental Analysis
USA - NYSE:CLB - US21867A1051 - Common Stock
16.11 USD
-0.36 (-2.19%)
16.2 USD
+0.09 (+0.56%)
Overall CLB gets a fundamental rating of 5 out of 10. We evaluated CLB against 60 industry peers in the Energy Equipment & Services industry. CLB is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. CLB does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
CLB had positive earnings in the past year.
CLB had a positive operating cash flow in the past year.
Of the past 5 years CLB 4 years were profitable.
Each year in the past 5 years CLB had a positive operating cash flow.
1.2 Ratios
CLB has a better Return On Assets (5.43%) than 70.00% of its industry peers.
CLB has a Return On Equity of 11.84%. This is in the better half of the industry: CLB outperforms 68.33% of its industry peers.
CLB has a better Return On Invested Capital (9.29%) than 71.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CLB is in line with the industry average of 7.85%.
The 3 year average ROIC (8.80%) for CLB is below the current ROIC(9.29%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.43% | ||
| ROE | 11.84% | ||
| ROIC | 9.29% |
ROA(3y)4.98%
ROA(5y)0.23%
ROE(3y)13.12%
ROE(5y)-16.91%
ROIC(3y)8.8%
ROIC(5y)8.69%
1.3 Margins
CLB has a Profit Margin (6.21%) which is comparable to the rest of the industry.
CLB's Profit Margin has declined in the last couple of years.
CLB has a Operating Margin of 11.16%. This is in the better half of the industry: CLB outperforms 61.67% of its industry peers.
CLB's Operating Margin has declined in the last couple of years.
CLB has a Gross Margin of 19.95%. This is in the lower half of the industry: CLB underperforms 71.67% of its industry peers.
In the last couple of years the Gross Margin of CLB has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.16% | ||
| PM (TTM) | 6.21% | ||
| GM | 19.95% |
OM growth 3Y7.68%
OM growth 5Y-4.33%
PM growth 3Y12.69%
PM growth 5Y-17.05%
GM growth 3Y-3.24%
GM growth 5Y-5.25%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CLB is still creating some value.
The number of shares outstanding for CLB remains at a similar level compared to 1 year ago.
CLB has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CLB has been reduced compared to a year ago.
2.2 Solvency
CLB has an Altman-Z score of 3.32. This indicates that CLB is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 3.32, CLB belongs to the best of the industry, outperforming 81.67% of the companies in the same industry.
The Debt to FCF ratio of CLB is 3.32, which is a good value as it means it would take CLB, 3.32 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.32, CLB is in the better half of the industry, outperforming 61.67% of the companies in the same industry.
CLB has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
CLB has a Debt to Equity ratio of 0.42. This is comparable to the rest of the industry: CLB outperforms 50.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 3.32 | ||
| Altman-Z | 3.32 |
ROIC/WACC1.08
WACC8.59%
2.3 Liquidity
CLB has a Current Ratio of 2.37. This indicates that CLB is financially healthy and has no problem in meeting its short term obligations.
CLB has a better Current ratio (2.37) than 68.33% of its industry peers.
A Quick Ratio of 1.76 indicates that CLB should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.76, CLB is doing good in the industry, outperforming 65.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.37 | ||
| Quick Ratio | 1.76 |
3. Growth
3.1 Past
The earnings per share for CLB have decreased by -9.41% in the last year.
The earnings per share for CLB have been decreasing by -13.14% on average. This is quite bad
Looking at the last year, CLB shows a decrease in Revenue. The Revenue has decreased by -1.02% in the last year.
Measured over the past years, CLB shows a decrease in Revenue. The Revenue has been decreasing by -4.75% on average per year.
EPS 1Y (TTM)-9.41%
EPS 3Y7.42%
EPS 5Y-13.14%
EPS Q2Q%-12%
Revenue 1Y (TTM)-1.02%
Revenue growth 3Y3.66%
Revenue growth 5Y-4.75%
Sales Q2Q%0.09%
3.2 Future
The Earnings Per Share is expected to grow by 12.78% on average over the next years. This is quite good.
CLB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.47% yearly.
EPS Next Y-13.84%
EPS Next 2Y-2.32%
EPS Next 3Y-0.94%
EPS Next 5Y12.78%
Revenue Next Year-2.71%
Revenue Next 2Y0.74%
Revenue Next 3Y-1.03%
Revenue Next 5Y3.47%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 20.92, which indicates a rather expensive current valuation of CLB.
The rest of the industry has a similar Price/Earnings ratio as CLB.
CLB's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.76.
With a Price/Forward Earnings ratio of 19.19, CLB is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CLB is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.63, CLB is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.92 | ||
| Fwd PE | 19.19 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLB indicates a rather expensive valuation: CLB more expensive than 85.00% of the companies listed in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as CLB.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.97 | ||
| EV/EBITDA | 11.88 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.32%
EPS Next 3Y-0.94%
5. Dividend
5.1 Amount
With a yearly dividend of 0.24%, CLB is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.01, CLB has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.31, CLB's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.24% |
5.2 History
The dividend of CLB decreases each year by -55.13%.
CLB has paid a dividend for at least 10 years, which is a reliable track record.
CLB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-55.13%
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
5.83% of the earnings are spent on dividend by CLB. This is a low number and sustainable payout ratio.
DP5.83%
EPS Next 2Y-2.32%
EPS Next 3Y-0.94%
16.11
-0.36 (-2.19%)
Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)
Earnings (Next)
Inst Owners114.84%
Inst Owner Change-0.2%
Ins Owners1.04%
Ins Owner Change0.1%
Market Cap755.40M
Revenue(TTM)517.50M
Net Income(TTM)32.12M
Analysts49.09
Price Target15.64 (-2.92%)
Short Float %13.82%
Short Ratio11.27
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.24% |
Yearly Dividend0.04
Dividend Growth(5Y)-55.13%
DP5.83%
Div Incr Years0
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.26%
Min EPS beat(2)-0.33%
Max EPS beat(2)12.86%
EPS beat(4)1
Avg EPS beat(4)1.9%
Min EPS beat(4)-4.67%
Max EPS beat(4)12.86%
EPS beat(8)4
Avg EPS beat(8)4.82%
EPS beat(12)7
Avg EPS beat(12)5.16%
EPS beat(16)8
Avg EPS beat(16)3.39%
Revenue beat(2)2
Avg Revenue beat(2)0.73%
Min Revenue beat(2)0.02%
Max Revenue beat(2)1.44%
Revenue beat(4)2
Avg Revenue beat(4)-0.96%
Min Revenue beat(4)-3.38%
Max Revenue beat(4)1.44%
Revenue beat(8)3
Avg Revenue beat(8)-0.5%
Revenue beat(12)4
Avg Revenue beat(12)-1.2%
Revenue beat(16)5
Avg Revenue beat(16)-1.06%
PT rev (1m)0%
PT rev (3m)-4.51%
EPS NQ rev (1m)-1.7%
EPS NQ rev (3m)-12.37%
EPS NY rev (1m)-0.44%
EPS NY rev (3m)-2.19%
Revenue NQ rev (1m)0.29%
Revenue NQ rev (3m)1.31%
Revenue NY rev (1m)0.3%
Revenue NY rev (3m)0.55%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.92 | ||
| Fwd PE | 19.19 | ||
| P/S | 1.46 | ||
| P/FCF | 21.97 | ||
| P/OCF | 15.2 | ||
| P/B | 2.78 | ||
| P/tB | 4.57 | ||
| EV/EBITDA | 11.88 |
EPS(TTM)0.77
EY4.78%
EPS(NY)0.84
Fwd EY5.21%
FCF(TTM)0.73
FCFY4.55%
OCF(TTM)1.06
OCFY6.58%
SpS11.04
BVpS5.79
TBVpS3.52
PEG (NY)N/A
PEG (5Y)N/A
Graham Number10.01
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.43% | ||
| ROE | 11.84% | ||
| ROCE | 11.66% | ||
| ROIC | 9.29% | ||
| ROICexc | 9.8% | ||
| ROICexgc | 12.66% | ||
| OM | 11.16% | ||
| PM (TTM) | 6.21% | ||
| GM | 19.95% | ||
| FCFM | 6.64% |
ROA(3y)4.98%
ROA(5y)0.23%
ROE(3y)13.12%
ROE(5y)-16.91%
ROIC(3y)8.8%
ROIC(5y)8.69%
ROICexc(3y)9.11%
ROICexc(5y)8.99%
ROICexgc(3y)11.75%
ROICexgc(5y)11.63%
ROCE(3y)11.03%
ROCE(5y)10.9%
ROICexgc growth 3Y11.32%
ROICexgc growth 5Y-6.37%
ROICexc growth 3Y11.52%
ROICexc growth 5Y-2.86%
OM growth 3Y7.68%
OM growth 5Y-4.33%
PM growth 3Y12.69%
PM growth 5Y-17.05%
GM growth 3Y-3.24%
GM growth 5Y-5.25%
F-Score7
Asset Turnover0.88
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 3.32 | ||
| Debt/EBITDA | 1.58 | ||
| Cap/Depr | 104.6% | ||
| Cap/Sales | 2.96% | ||
| Interest Coverage | 6.66 | ||
| Cash Conversion | 68.62% | ||
| Profit Quality | 107.03% | ||
| Current Ratio | 2.37 | ||
| Quick Ratio | 1.76 | ||
| Altman-Z | 3.32 |
F-Score7
WACC8.59%
ROIC/WACC1.08
Cap/Depr(3y)71.15%
Cap/Depr(5y)68.67%
Cap/Sales(3y)2.22%
Cap/Sales(5y)2.39%
Profit Quality(3y)84.24%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.41%
EPS 3Y7.42%
EPS 5Y-13.14%
EPS Q2Q%-12%
EPS Next Y-13.84%
EPS Next 2Y-2.32%
EPS Next 3Y-0.94%
EPS Next 5Y12.78%
Revenue 1Y (TTM)-1.02%
Revenue growth 3Y3.66%
Revenue growth 5Y-4.75%
Sales Q2Q%0.09%
Revenue Next Year-2.71%
Revenue Next 2Y0.74%
Revenue Next 3Y-1.03%
Revenue Next 5Y3.47%
EBIT growth 1Y-6.83%
EBIT growth 3Y11.62%
EBIT growth 5Y-8.87%
EBIT Next Year8.35%
EBIT Next 3Y4.07%
EBIT Next 5Y17.46%
FCF growth 1Y286.32%
FCF growth 3Y23.36%
FCF growth 5Y-8.39%
OCF growth 1Y165.78%
OCF growth 3Y15.5%
OCF growth 5Y-8.83%
CORE LABORATORIES INC / CLB FAQ
Can you provide the ChartMill fundamental rating for CORE LABORATORIES INC?
ChartMill assigns a fundamental rating of 5 / 10 to CLB.
What is the valuation status for CLB stock?
ChartMill assigns a valuation rating of 2 / 10 to CORE LABORATORIES INC (CLB). This can be considered as Overvalued.
Can you provide the profitability details for CORE LABORATORIES INC?
CORE LABORATORIES INC (CLB) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for CLB stock?
The Price/Earnings (PE) ratio for CORE LABORATORIES INC (CLB) is 20.92 and the Price/Book (PB) ratio is 2.78.
Can you provide the financial health for CLB stock?
The financial health rating of CORE LABORATORIES INC (CLB) is 7 / 10.